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ABSTRACT
Objective: The proportion of people with mental
health disorders who participate in clinical research
studies is much smaller than for those with physical
health disorders. It is sometimes assumed that this
reflects an unwillingness to volunteer for mental health
research studies. We examined this issue in a large
sample of patients with psychosis.
Design: Cross-sectional study.
Setting: Anonymised electronic mental health record
data from the South London and Maudsley NHS
Foundation Trust (SLaM).
Participants: 5787 adults diagnosed with a psychotic
disorder.
Exposure: Whether approached prior to 1 September
2014 for consent to be approached about research
participation.
Main outcome measures: Number of days spent in
a psychiatric hospital, whether admitted to hospital
compulsorily, and total score on the Health of the
Nation Outcome Scale (HoNOS) between 1 September
2014 and 28 February 2015 with patient factors (age,
gender, ethnicity, marital status and diagnosis) and
treating clinical service as covariates.
Results: 1187 patients (20.5% of the total sample)
had been approached about research participation. Of
those who were approached, 773 (65.1%) agreed to be
contacted in future by researchers. Patients who had
been approached had 2.3 fewer inpatient days (95% CI
−4.4 to −0.3, p=0.03), were less likely to have had a
compulsory admission (OR 0.65, 95% CI 0.50 to 0.84,
p=0.001) and had a better HoNOS score (β coefficient
−0.9, 95% CI −1.5 to −0.4, p=0.001) than those who
had not. Among patients who were approached, there
was no significant difference in clinical outcomes
between those agreed to research contact and those
who did not.
Conclusions: About two-thirds of patients with
psychotic disorders were willing to be contacted about
participation in research. The patients who were
approached had better clinical outcomes than those
who were not, suggesting that clinicians were more
likely to approach patients who were less unwell.
INTRODUCTION
Patient recruitment is often cited as a chal-
lenge in conducting research in mental
health, particularly in people with psychotic
disorders.1–3 The National Institute for
Health Research (NIHR) performance
report for 2013/2014 showed that only ﬁve
mental healthcare providers were among the
top 100 performing healthcare providers
recruiting to clinical research.4 One poten-
tial contributing factor is the marked discrep-
ancy in research funding for mental and
physical healthcare. In the UK, only £9.75 of
mental health research funding is invested
for each affected individual, compared with
£1571 for cancer research funding.5
Furthermore, in physical healthcare, patients
who participate in research, or who are
treated in healthcare organisations that take
part in clinical research, are likely to have
better clinical outcomes.6 7 For example, a
recent systematic review7 found that patients
Strengths and limitations of this study
▪ Our study investigates a large sample of patients
with psychotic disorders to determine the pro-
portion who consented to be contacted to par-
ticipate in clinical research. We found that most
patients were willing to be contacted but that
clinicians tended to approach patients who were
less unwell.
▪ As this was an observational study, it was not
possible to determine the explanation for
observed variation in rates of consent which are
likely to depend on a combination of patient and
healthcare service-related factors.
▪ Our study may have been affected by selection
bias as clinicians may have approached patients
who were perceived to be more likely to provide
consent to contact for research participation.
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at centres that conducted clinical trials had better out-
comes than patients treated at centres not involved in
research.
Patient involvement is an integral part of mental
health research.8 Indeed patient involvement has gained
momentum in mental health research over the years as
a number of studies have examined the association of
user participation and beneﬁt for research. Ennis and
Wykes9 found that research studies that involved patients
in study design and implementation were more likely
to meet their recruitment target. Goodwin et al10
highlighted the importance of patient input in a study
developing an electronic patient reporting application.
Other studies have considered patient attitude towards
engaging in research reporting facilitators and barriers
such as altruism, reassurance about conﬁdentiality,
access to study centre, ethnic minority status, stigma and
distrust in mental healthcare services.11–13
Despite these advances, it is unclear whether research
participation among people with mental disorders contri-
butes to better clinical outcomes (as seen in physical
healthcare) or if staff are more likely to approach patients
about research if they have a relatively good prognosis.
Electronic health records can play a vital role in
improving access to clinical research opportunities
through consent for contact (C4C) programme whereby
clinicians may ask their patients whether they might be
interested in being contacted about relevant research
opportunities and, if so, give permission to be invited to
participate in research.14–16
The ﬁrst aim of the present study was to determine
the proportion of patients with psychotic disorders who
were willing, in principle, to participate in research. The
second objective was to assess whether patients who were
approached about research were different to those who
were not approached, in terms of their demographic
and clinical features, and clinical outcomes. We
addressed these issues by accessing an electronic data-
base which contained the clinical records from a large
sample of patients with a psychotic disorder. We have
chosen to focus on patients with a diagnosis of a psych-
otic disorder because evidence suggests that there are
challenges engaging this particular group in research.17
METHODS
Study setting and participants
The study was conducted using clinical data from the
pseudonymised electronic health records of patients
receiving mental healthcare from the South London
and Maudsley NHS Foundation Trust (SLaM). SLaM
provides mental healthcare for the residents of
Lambeth, Southwark, Croydon and Lewisham in
London, with a total population of 1.5 million. Services
for patients with psychotic disorders comprise 74 com-
munity and inpatient teams.
The present study analysed data from adults (aged
over 16 years) diagnosed with a psychotic disorder and
receiving care from in SLaM between 1 September 2014
and 28 February 2015. Diagnosis of a psychotic disorder
was deﬁned according to the International Classiﬁcation
of Diseases (ICD)-10 classiﬁcation system and included
schizophrenia or related disorders (schizophrenia (F20),
delusional disorder (F22), schizophrenia-like disorders
(F23, F28, F29)), schizoaffective disorder (F25), mania
or bipolar disorder with psychotic symptoms (F30, F31),
psychotic depression (F32.3, F33.3), drug-induced psych-
osis (F1x.5) and any other psychotic disorder not other-
wise speciﬁed. Using these criteria, data from 5787
people were obtained and included in the present study.
Source of clinical data
Data were obtained from the SLaM Biomedical Research
Centre (BRC) Case Register,18 19 a large data set con-
taining pseudonymised clinical data of over 270 000
patients derived from the electronic Patient Journey
System (ePJS). ePJS is an electronic health record system
which has been used in all SLaM clinical services since
April 2006. Healthcare professionals use ePJS to docu-
ment all clinical information. The clinical information
documented includes structured ﬁelds (for demo-
graphic information) and de-identiﬁed unstructured
free-text ﬁelds from case notes and correspondence.
Data for this study were obtained from these sources of
clinical data using the Clinical Record Interactive Search
tool (CRIS). CRIS is a bespoke database search and as-
sembly tool which has supported a range of studies20–25
using clinical data from the SLaM BRC Case Register.
C4C programme
The SLaM C4C programme was developed to facilitate
recruitment of patients into mental health research
studies. A full description of programme development,
method and implementation are provided in a previous
paper.14 In summary, the programme relies on the inte-
gration of the ePJS system with the SLaM BRC Case
Register and CRIS. Taking consent involves healthcare
professionals asking patients whether they would be
willing to be contacted (at a later date) by a researcher
if they were eligible for a research study on the basis of
reviewing their anonymised electronic health records.
Patients’ responses to this question (whether providing
or refusing consent) are recorded in ePJS. Researchers
who are conducting clinical studies can then use the
CRIS tool to search the SLaM BRC Case Register to
identify and contact patients who are willing to be
approached about participation in a research project.
Ethical approval and research governance
The SLaM BRC Case Register and CRIS have received
ethical approval from the Oxfordshire Research Ethics
Committee C (08/H0606/71+5) as a pseudonymised
data set for mental health research.26 The SLaM C4C
model was reviewed and approved by the National
Information Governance Board for Health and Social
Care (NIGB) Ethics and Conﬁdentiality committee
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(reference ECC 2-08/2010).14 A patient-led oversight
committee provides governance for all projects con-
ducted using these data, including those that use the
C4C programme. Research studies can only be regis-
tered with the C4C programme if they have received
approval from a UK Research Ethics Committee. A
robust ﬁrewall and data security framework governs
access to clinical data from the case register and only
approved researchers are permitted to access data from
the case register.26
Exposure
The exposure was deﬁned as whether or not patients
had been approached for consent to participate in
research prior to 1 September 2014. This deﬁnition was
chosen to ensure that the exposure always occurred
prior to the measurement of the clinical outcome
measures.
Clinical outcome measures
The primary outcome measure was the number of days
spent as an inpatient in a psychiatric hospital in SLaM
between 1 September 2014 and 28 February 2015. This
represents a robust marker of illness severity from the
patients’ perspective, as well as its impact on family and
carers, and on mental healthcare services. Secondary
outcome measures included whether or not the admis-
sion had been compulsory, under the UK Mental Health
Act,27 and the ﬁrst recorded total score on the Health of
the Nation Outcome Scale (HoNOS) recorded between
1 September 2014 and 28 February 2015. HoNOS is a
scale of illness severity which is routinely recorded in
UK mental healthcare services.28 The scale covers 12
domains: overactive, aggressive, disruptive or agitated
behaviour; non-accidental self-injury; problem drinking
or drug-taking; cognitive problems; physical illness or
disability problems; problems associated with hallucina-
tions and delusions; problems with depressed mood;
other mental and behavioural problems; problems with
relationships; problems with activities of daily living; pro-
blems with living conditions; problems with occupation
and activities. Each domain is scored on a scale of 0–4
with a maximum possible total score of 48. The total
score was chosen as a secondary outcome in order to
capture a measure of illness severity that would apply to
outpatients as well as inpatients. Complete outcome data
were available for the primary outcome measure and
compulsory hospital admission. HoNOS score data were
available for 3052 (52.7%) of patients included in the
study.
Covariates
The following variables were extracted as categorical cov-
ariates for multivariable analyses: age, gender, ethnicity,
marital status, diagnosis and the clinical service provid-
ing care to the patient. The number of hospital admis-
sions between 1 September 2011 and 31 August 2014
was extracted as a continuous covariate. All categorical
covariate data obtained were those recorded closest to 1
September 2014. Ethnicity was recorded according to cat-
egories deﬁned by the UK Ofﬁce for National Statistics.29
Marital status was recorded in the following categories:
married or cohabiting; divorced or separated; single;
unknown. Diagnosis was deﬁned according to the groups
described in the Study setting and participants section.
Statistical analysis
Stata (V.12.0) was used to analyse the data (StataCorp.
Stata Statistical Software: Release 12. Coll Station, TX:
StataCorp LP, 2011). Descriptive statistics for the expos-
ure, outcome and covariate variables were obtained as
frequencies and percentages for categorical variables
and means and SDs for continuous variables. In order
to assess whether there were any patient factors (age;
gender; ethnicity; marital status; diagnosis) or mental
health service-related factors (clinical service) associated
with being approached for (C4C), the associations of
patient factors with being approached for consent were
tested ﬁrst individually with univariate binary logistic
regression followed by a multivariable binary logistic
regression analysis adjusted for patient factors and clin-
ical service. A further analysis on patients who were
approached for consent was undertaken to investigate
the association between whether or not patients gave
consent and patient and mental health service-related
factors using the same univariate and multivariable
binary logistic regression method.
The associations of being approached for consent
with number of inpatient days and with total HoNOS
score were tested using multiple linear regression. The
association between being approached for consent and
compulsory hospital admission was tested using multi-
variable binary logistic regression. The association of
number of hospital admissions between 1 September
2011 and 31 August 2014 with each clinical outcome
measure was tested separately in univariate analyses and
found to be a signiﬁcant predictor of all clinical out-
comes measures: number of inpatient days β coefﬁcient
6.0 (95% CI 5.4 to 6.6, p<0.001); compulsory hospital
admission OR 1.35 (1.28 to 1.42, p<0.001); total
HoNOS score β coefﬁcient 0.5 (0.3 to 0.6, p<0.001). For
this reason, four regression models were generated for
each analysis of association with clinical outcome
measures as follows:
▸ Model 1: unadjusted;
▸ Model 2: adjusted for number of hospital admissions
between 1 September 2011 and 31 August 2014;
▸ Model 3: adjusted for all factors in model 2 plus age,
gender, ethnicity, marital status and diagnosis;
▸ Model 4: adjusted for all factors in model 3 plus clini-
cal service.
This stepwise approach was chosen in order to ﬁrst
examine the effect of adjusting for number of prior hos-
pital admissions (model 2) before adjusting for patient-
related factors (model 3) and then mental health
service-related factors (model 4).
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A further analysis on patients who were approached
for consent was undertaken to investigate the association
between whether or not patients gave consent and clini-
cal outcome methods using the same stepwise regression
method. Where there was missing data in covariate data
(184 patients with no known marital status), the missing
data category was included as a predictor variable in
regression analyses.
RESULTS
C4C and patient and mental healthcare service-related
factors
Of the 5787 patients included in the study, 1187
(20.5%) had been approached for C4C to participate in
research. Nine hundred and forty-seven patients had
been approached in the community and 240 after they
had been admitted to hospital. Of those approached,
773 (65.1%) gave consent to be contacted about partici-
pation in future research studies.
Table 1 shows the breakdown of who was approached
by patient-related factors. Univariate regression analysis
showed that patients aged between 46 and 55 years were
the most likely to be approached, but that there was no
difference between men and women. Black patients were
more likely to be approached than white, Asian and
other ethnic groups. Patients who were married or coha-
biting were less likely to be approached compared with
those who were single. Patients with psychotic depression
were less likely to be approached compared with patients
with schizophrenia or related disorders. Patients with a
greater number of admissions between 1 September 2011
and 31 August 2014 were more likely to be approached.
However, after adjusting for all factors in a multivariable
analysis, there was no longer a signiﬁcant difference in
being approached among patients with demographic
factors or between different diagnostic groups.
A further analysis of the patients who were approached
for consent to examine the association of whether
patients gave consent with patient factors (table 2)
demonstrated that patients aged between 16 and
25 years were most likely to give consent compared with
other age groups. The factor most strongly associated
with giving consent was if patients were approached
while they were in hospital rather than as outpatients.
Clinical outcomes
Number of inpatient days
The mean number of days which patients spent in hos-
pital between 1 September 2014 and 28 February 2015
was 9.5 (SD 31.4). Those who had been approached for
consent spent fewer days in hospital (mean 8.8, SD 29.5)
than those who had not been approached (mean 9.6,SD
31.9). There was no signiﬁcant difference between the
two groups in univariate analysis (table 3, model 1), but
multiple linear regression analysis (table 3, models 2–4)
revealed a signiﬁcant association between being
approached for consent and spending fewer days in
hospital, after adjusting for patient and mental health
service-related factors. Within the group of patients who
were approached, there was no signiﬁcant association
between whether consent was or was not given and the
number of days spent in hospital (table 4).
Compulsory hospital admission under the UK Mental
Health Act
The overall proportion of patients who were compulsor-
ily admitted between 1 September 2014 and 28 February
2015 was 9.2%. Those who had been approached for
consent were less likely to be compulsorily admitted
(8.0%) than those who had not been approached
(9.6%). There was no signiﬁcant difference between the
two groups in univariate analysis (table 3, model 1) but
multiple linear regression analysis (table 3, models 2–4)
revealed a signiﬁcant association between being
approached for consent and a reduced likelihood of
compulsory admission, after adjusting for patient and
mental health service-related factors. Among patients
who had been approached, there was no signiﬁcant asso-
ciation between whether consent had been given and
the likelihood of compulsory admission (table 4).
Health of the Nation Outcome Scale
The overall mean total HoNOS score was 12.4 (SD 6.4).
Those who had been approached for consent had a
lower total HoNOS score (mean 11.7, SD 6.2) than
those who had not been approached (mean 12.6, SD
6.5). Linear regression analysis (table 3) revealed a sig-
niﬁcant association between being approached and a
lower total HoNOS score, both in univariate analysis
(model 1) and in multiple linear regression analysis
(models 2–4) adjusting for patient and mental health
service-related factors. Among those approached, there
was no signiﬁcant association between whether consent
was given and the mean total HoNOS score (table 4).
DISCUSSION
Main findings
In this study, we investigated the proportion of patients
with psychotic disorder who were willing to participate
in research and assessed demographic and clinical
factors that were associated with being approached for
consent to be contacted to participate in research
studies. We studied a large sample that is representative
of people with psychotic disorders who receive care
from inner city mental health services in the UK. We
found that the majority of those approached were
willing to be contacted in future about participation in
research projects. Although univariate analyses suggested
variation in the age, gender, ethnicity, marital status and
diagnosis in relation to whether or not patients were
approached for consent, multivariable analyses indicated
that variation was largely related to mental health
service-related factors than patient factors. An increase
in number of previous hospital admissions was
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Table 1 Binary logistic regression analysis of patient and service-related factors associated with being approached for C4C, n=5787
Factor Group
Number
in sample
Percentage
approached
for consent (%) Unadjusted OR 95% CI, p value Adjusted OR* 95% CI, p value
Age Age 16–25 years 726 18.9 Reference Reference
26–35 1134 19.9 1.07 0.84 to 1.36, p=0.57 0.75 0.58 to 0.98, p=0.03
36–45 1225 19.8 1.06 0.84 to 1.34, p=0.63 0.64 0.48 to 0.85, p=0.002
46–55 1360 24.2 1.37 1.10 to 1.72, p=0.006 0.81 0.61 to 1.06, p=0.12
56–65 687 21.5 1.18 0.91 to 1.53, p=0.21 0.77 0.56 to 1.06, p=0.11
>65 655 16.0 0.82 0.62 to 1.09, p=0.17 0.74 0.53 to 1.03, p=0.07
Gender Female 2394 20.5 1.00 0.88 to 1.14, p=1.00 1.00 0.87 to 1.16, p=0.97
Male 3393 20.5 Reference Reference
Ethnicity White 2602 19.9 Reference Reference
Asian 365 16.2 0.78 0.58 to 1.04, p=0.09 0.85 0.62 to 1.17, p=0.33
Black 2313 23.4 1.23 1.07 to 1.41, p=0.003 0.97 0.83 to 1.13, p=0.69
Other ethnic group 507 13.8 0.65 0.49 to 0.85, p=0.002 0.69 0.51 to 0.92, p=0.01
Marital status Married/cohabiting 704 16.5 0.72 0.58 to 0.89, p=0.002 0.75 0.59 to 0.95, p=0.02
Divorced/separated 518 23.6 1.13 0.91 to 1.40, p=0.28 0.96 0.75 to 1.22, p=0.73
Single 4381 21.5 Reference Reference
Marital status unknown 184 4.3 0.17 0.08 to 0.34, p<0.001 0.32 0.15 to 0.66, p=0.002
Diagnosis Schizophrenia and related 3705 20.8 Reference Reference
Schizoaffective 288 24.3 1.22 0.92 to 1.62, p=0.17 1.20 0.88 to 1.64, p=0.25
Bipolar disorder 366 23.2 1.15 0.89 to 1.48, p=0.29 0.88 0.66 to 1.18, p=0.39
Psychotic depression 558 15.9 0.72 0.57 to 0.92, p=0.008 0.86 0.66 to 1.12, p=0.26
Drug-induced psychosis 173 18.5 0.86 0.58 to 1.28, p=0.46 0.95 0.62 to 1.46, p=0.81
Other psychosis 697 19.9 0.95 0.77 to 1.16, p=0.59 0.93 0.75 to 1.16, p=0.52
Number of admissions between 1 September 2011 and 31 August 2014 1.28 1.22 to 1.34, p<0.001 1.28 1.22 to 1.34, p<0.001
*Adjusted for age, gender, ethnicity, marital status, diagnosis, number of admissions between 1 September 2011 and 31 August 2014, and clinical service.
C4C, consent for contact.
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Table 2 Binary logistic regression analysis of patient and service-related factors associated with whether consent was given, n=1187
Factor Group
Number
in sample
Percentage
giving
consent (%)
Unadjusted
OR 95% CI, p value
Adjusted
OR* 95% CI, p value
Age Age 16–25 years 137 81.0 Reference Reference
26–35 226 73.5 0.65 0.39 to 1.09, p=0.10 0.98 0.54 to 1.77, p=0.94
36–45 242 65.3 0.44 0.27 to 0.73, p=0.001 0.72 0.40 to 1.32, p=0.29
46–55 329 60.5 0.36 0.22 to 0.58, p<0.001 0.62 0.34 to 1.11, p=0.11
56–65 148 63.5 0.41 0.24 to 0.70, p=0.001 0.65 0.34 to 1.26, p=0.20
>65 105 42.9 0.18 0.10 to 0.31, p<0.001 0.28 0.14 to 0.55, p<0.001
Gender Female 491 64.4 0.94 0.74 to 1.20, p=0.64 0.86 0.65 to 1.13, p=0.27
Male 696 65.7 Reference Reference
Ethnicity White 517 66.5 Reference Reference
Asian 59 71.2 1.24 0.69 to 2.25, p=0.47 1.11 0.58 to 2.12, p=0.75
Black 541 63.0 0.86 0.67 to 1.10, p=0.23 0.73 0.55 to 0.97, p=0.03
Other ethnic group 70 65.7 0.96 0.57 to 1.63, p=0.89 0.91 0.51 to 1.62, p=0.74
Marital status Married/cohabiting 116 62.9 0.88 0.59 to 1.32, p=0.54 1.21 0.77 to 1.91, p=0.41
Divorced/separated 122 60.7 0.80 0.54 to 1.18, p=0.26 1.05 0.67 to 1.65, p=0.83
Single 941 65.8 Reference Reference
Marital status unknown 8 87.5 3.64 0.45 to 29.7, p=0.23 2.88 0.30 to 27.6, p=0.36
Diagnosis Schizophrenia and related 772 62.7 Reference Reference
Schizoaffective 70 62.9 1.01 0.61 to 1.67, p=0.98 1.08 0.62 to 1.87, p=0.80
Bipolar disorder 85 68.2 1.28 0.79 to 2.06, p=0.32 1.03 0.61 to 1.75, p=0.91
Psychotic depression 89 75.3 1.81 1.10 to 3.00, p=0.02 1.60 0.92 to 2.77, p=0.10
Drug-induced psychosis 32 84.4 3.21 1.22 to 8.44, p=0.02 1.69 0.58 to 4.92, p=0.34
Other psychosis 139 66.9 1.20 0.82 to 1.76, p=0.34 0.99 0.65 to 1.52, p=0.96
Location Inpatient 240 93.8 10.92 6.38 to 18.7, p<0.001 7.89 4.48 to 13.91, p<0.001
Outpatient 947 57.9 Reference Reference
*Adjusted for age, gender, ethnicity, marital status, diagnosis, location and clinical service.
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associated with an increased likelihood of being
approached for consent. This might reﬂect the fact that
patients who have multiple hospital admissions have
greater opportunity to be approached for consent
simply by virtue of more frequent contact with mental
healthcare services with repeated opportunities to be
approached for consent across multiple admissions. This
is corroborated by the ﬁnding that patients were more
likely to give consent if they were approached while in
hospital (where there may have been multiple opportun-
ities to discuss consent) rather than in the community.
We found that the patients who were approached for
consent had fewer inpatients days, were less likely to be
admitted to hospital compulsorily, and had lower
HoNOS scores. It is possible that patients who appeared
to be less severely unwell were more likely to be
approached because the clinical staff perceived them as
being more likely to tolerate participation in research.
Furthermore, patients with severe illness may be per-
ceived as lacking capacity to consent. Patients with a rela-
tively good prognosis may have been more engaged with
the clinical teams, and that this increased the likelihood
of them being approached. We did not ﬁnd any signiﬁ-
cant differences between patients who subsequently
agreed to take part in research and those who did not.
This may reﬂect the fact that clinician factors, such as
how potential beneﬁts and risks of being involved in
clinical research are conveyed to patients or the enthusi-
asm of individual clinicians to encourage patients to be
involved in research studies (which we were unable to
measure in the present study), also have an important
role in determining the likelihood of agreeing to partici-
pate in research. This is corroborated by the fact that
adjusting for which clinical service a patient was receiv-
ing care from reduced or eliminated associations with
individual patient factors seen in univariate analyses.
Relationship to previous studies
We found a slightly lower level (65.1%) of consent than
Callard et al14 who reported a 74.1% consent rate to par-
ticipate in mental health research. However, they did
not speciﬁcally study patients with psychotic disorders
but all psychiatric disorders. Our results are in keeping
with a recent study11 which found around 60% of those
invited to participate in a research study agreed to do
so. In a Canadian study of implementing a ‘permission
to contact’ programme, Cheah et al30 reported overall
consent rates ranging between 80% (congenital heart
disease) and 90% (cancer). This may echo the chal-
lenges of recruiting patients with psychotic disorders
into clinical studies. A possible explanation for reduced
rates of consent in people with psychotic disorders is
Table 3 Association of being approached for consent with clinical outcome measures between 1 September 2014 and
28 February 2015, n=5787
Number of inpatient days (n=5787)
Compulsory hospital
admission (n=5787) Change in total HoNOS score (n=3052)
Model
β coefficient
(days) 95% CI, p value OR 95% CI, p value
β coefficient
(per unit HoNOS) 95% CI, p value
1 −0.8 −2.8 to 1.2, p=0.41 0.82 0.65 to 1.04, p=0.10 −0.8 −1.4 to −0.3, p=0.003
2 −3.8 −5.8 to −1.8, p<0.001 0.65 0.51 to 0.83, p=0.001 −1.2 −1.7 to −0.6, p<0.001
3 −3.7 −5.6 to −1.7, p<0.001 0.64 0.50 to 0.82, p<0.001 −1.2 −1.8 to −0.7, p<0.001
4 −2.3 −4.4 to −0.3, p=0.03 0.65 0.50 to 0.84, p=0.001 −0.9 −1.5 to −0.4, p=0.001
Model 1: unadjusted.
Model 2: adjusted for number of hospital admissions between 1 September 2011 and 31 August 2014.
Model 3: adjusted for all factors in model 2 plus age, gender, ethnicity, marital status and diagnosis.
Model 4: adjusted for all factors in model 3 plus clinical service.
HoNOS, Health of the Nation Outcome Scale.
Table 4 Association of giving consent with clinical outcome measures between 1 September 2014 and 28 February 2015,
n=1187
Number of inpatient days
(n=1187)
Compulsory hospital
admission (n=1187) Change in total HoNOS score (n=678)
Model
β coefficient
(days) 95% CI, p value OR 95% CI, p value
β coefficient
(per unit HoNOS) 95% CI, p value
1 4.3 0.8 to 7.9, p=0.02 1.38 0.87 to 2.20, p=0.17 −0.3 −1.3 to 0.7, p=0.58
2 2.4 −1.1 to 5.9, p=0.18 1.13 0.70 to 1.81, p=0.62 −0.7 −1.7 to 0.3, p=0.18
3 1.9 −1.6 to 5.4, p=0.30 1.10 0.67 to 1.79, p=0.72 −0.6 −1.7 to 0.4, p=0.23
4 1.6 −2.0 to 5.1, p=0.39 1.12 0.68 to 1.86, p=0.65 −0.6 −1.6 to 0.4, p=0.26
Model 1: unadjusted.
Model 2: adjusted for number of hospital admissions between 1 September 2011 and 31 August 2014.
Model 3: adjusted for all factors in model 2 plus age, gender, ethnicity, marital status and diagnosis.
Model 4: adjusted for all factors in model 3 plus clinical service.
HoNOS, Health of the Nation Outcome Scale.
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degree of insight into the illness and perceived need for
treatment. Some patients with a psychotic disorder do
not believe they are unwell or require treatment and
may therefore not believe in the need for research into
the disorder.31 Other factors associated with research
participation such as timing of the approach and com-
munication skills may also explain this variation.31
We found that individuals of black ethnic group were
less likely to give consent, in keeping with previous
studies.3 12 32 Conversely, individuals of ‘other’ ethnic
group were also less likely to be approached independ-
ent of potential confounders, a ﬁnding also reported in
other studies.13 33 Furthermore, our results showed that
younger patients were more likely to be approached for
consent, consistent with a previous study.2 One explan-
ation for this ﬁnding might be that mental healthcare
professionals believe that younger patients are more
likely to be interested in participating in mental health
research than older patients. However, our results also
indicated that older individuals were less likely to give
consent independent of potential confounders, as previ-
ously reported ﬁndings both in mental and physical
healthcare research.14 33
In addition, our results showed that only 20% of the
sample was approached for (C4C) and that patients in
hospital were more likely to be approached than patients
in the community. This may be explained by resource
issues as evidence suggests that clinicians struggle with
resources and support to devote time to research.34 35
Another possible contributory factor is the challenges of
recruiting patients with diagnosis of psychotic disorder
into clinical research.2 17
Strengths
The extent to which patients are willing to participate in
clinical research has already been established in other
areas of medicine such as oncology and cardiology.30 36
To the best of our knowledge, the present study is the
ﬁrst to examine this issue in patients with psychotic dis-
orders, and did this in a large sample that is representa-
tive of the population of patients that are seen by inner
city mental health services.
Limitations
The limitations of this study include its cross-sectional
observational design. Therefore, causality cannot be
inferred from the association of being approached for
consent (or giving consent when approached) with clini-
cal outcomes. As discussed previously, there are a
number of possible explanations for the associations of
consent with clinical outcomes and it is likely that these
are related to a complex set of patient and healthcare
service-related factors. There is a complex and multifac-
torial relationship between the factors analysed in this
study and the likelihood of being approached for consent
and giving consent. While we adjusted for individual
characteristics and service-related factors, our study could
still be confounded by unmeasured characteristics of the
services that were more likely to approach patients for
consent. It could be that these services have enthusiasm
and sustained research culture embedded in their prac-
tice thus making them more likely to discuss consent with
their patients. Although we have assumed that all persons
receiving care within SLaM would be asked about
consent, our study may still suffer selection bias as clini-
cians may have approached more settled and higher
functioning patients who may be more likely to say yes to
being approached for research. Patients may also be
more likely to be approached in clinical areas where C4C
implementation team is engaged. In addition, only
around 50% of patients had complete HoNOS data avail-
able and so it is possible that the associations of C4C with
HoNOS may not have accurately represented the whole
population. Furthermore, in this cross-sectional study it
was not possible to examine change in HoNOS score
which may have occurred during the course of receiving
mental healthcare.
Future research
The results of the current study highlight some import-
ant areas for further investigation. For instance, to deter-
mine why there were signiﬁcant differences in the
likelihood of being approached depending on patient
and mental health service-related factors. The decision
to participate in research may also partly depend on
how a potential participant is approached to gain
consent by individual clinicians. Future studies investigat-
ing patient and clinician factors may help to determine
how patients with psychotic disorders may better engage
with clinical research opportunities.
CONCLUSIONS
Most patients with psychosis were willing to be
approached about participation in research but only a
small proportion of patients were approached for
consent. Those who were approached tended to be
patients who were less severely unwell and had relatively
good clinical outcomes: this may reﬂect a bias of staff
towards considering less unwell patients for research.
Clinician factors may also be important in determining
likelihood of giving consent to participate in research
and further work is needed to increase research partici-
pation among individuals with psychotic disorders.
Author affiliations
1Department of Psychosis Studies, King’s College London, Institute of
Psychiatry, Psychology & Neuroscience, London, UK
2King’s College London, Health Service and Population Research, Institute of
Psychiatry, Psychology & Neuroscience, London, UK
3Department of Geography and Centre for Medical Humanities, Durham
University, Durham, UK
4Department of Psychology, King’s College London, Institute of Psychiatry,
Psychology & Neuroscience, London, UK
5South London and Maudsley NHS Foundation Trust, Biomedical Research
Centre Nucleus, Mapother House, London, UK
6Department of Psychological Medicine, King’s College London, Institute of
Psychiatry, Psychology & Neuroscience, London, UK
8 Patel R, et al. BMJ Open 2017;7:e013113. doi:10.1136/bmjopen-2016-013113
Open Access
Contributors The study was conceived by RP, SO, TKJC and PM. The data
extraction and statistical analysis was performed by RP. Reporting of findings
was carried out by RP and SO, supervised by TKJC and PM. All authors
contributed to manuscript preparation and approved the final version.
Funding MB, TW, PM, TKJC, SO and RS receive support from the National
Institute for Health Research (NIHR) Biomedical Research Centre and
Dementia Biomedical Research Unit at South London and Maudsley NHS
Foundation Trust and King’s College London, which also supports the
development and maintenance of the BRC Case Register. RP is supported by
a UK Medical Research Council (MRC) Clinical Research Training Fellowship
(MR/K002813/1). FC is supported by the Wellcome Trust (103817/Z/14/Z).
TW is supported by a NIHR Senior Investigator Award.
Competing interests All authors have completed the ICMJE uniform
disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: the
CRIS team MB and RS have received research funding from Roche, Pfizer,
Johnson & Johnson and Lundbeck. PM has received research funding from
Janssen, Sunovion, GW and Roche.
Ethics approval The CRIS data resource received ethical approval as an
anonymised data set for secondary analyses from Oxfordshire REC C (Ref:
08/H0606/71+5). The SLaM C4C model was reviewed and approved by the
National Information Governance Board for Health and Social Care (NIGB)
Ethics and Confidentiality committee (reference ECC 2-08/2010).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The data accessed by CRIS remain within an NHS
firewall and governance is provided by a patient-led oversight committee.
Subject to these conditions, data access is encouraged and those interested
should contact RS (robert.stewart@kcl.ac.uk), CRIS academic lead.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Bucci S, Butcher I, Hartley S, et al. Barriers and facilitators to
recruitment in mental health services: care coordinators’
expectations and experience of referring to a psychosis research
trial. Psychol Psychother 2015;88:335–50.
2. Howard L, de Salis I, Tomlin Z, et al. Why is recruitment to trials
difficult? An investigation into recruitment difficulties in an RCT of
supported employment in patients with severe mental illness.
Contemp Clin Trials 2009;30:40–6.
3. Patel MX, Doku V, Tennakoon L. Challenges in recruitment of
research participants. Adv Psychiatr Treat 2003;9:229–38.
4. NIHR Clinical Research Network. Top 100 Performing Trusts. 2014.
http://www.crn.nihr.ac.uk/about-crn/our-performance/key-statistics-2/
top-100-performing-trusts/
5. MQ: Transforming Mental Health. Mental Health Research Funding
Landscape Report. 2015. http://www.joinmq.org/pages/mental-
health-research-funding-landscape-report
6. Braunholtz DA, Edwards SJL, Lilford RJ. Are randomized clinical
trials good for us (in the short term)? Evidence for a ‘trial effect’.
J Clin Epidemiol 2001;54:217–24.
7. Clarke M, Loudon K. Effects on patients of their healthcare
practitioners or institutions participation in clinical trials: a systematic
review. Trials 2011;12:16.
8. Rose D. Service user involvement in mental health research. In:
Improving Mental Health Care - The Global Challenge. Thornicroft
G, Ruggeri M, Goldberg D (eds). Wiley-Blackwell, 2013;81–16.
9. Ennis L, Wykes T. Impact of patient involvement in mental health
research: longitudinal study. Br J Psychiatry 2013;203:381–6.
10. Goodwin J, Cummins J, Behan L, et al. Development of a mental
health smartphone app: perspectives of mental health service users.
J Ment Health 2016;25:434–440.
11. Robotham D, Waterman S, Oduola S, et al. Facilitating mental
health research for patients, clinicians and researchers:
a mixed-method study. BMJ Open 2016;6:e011127.
12. Woodall A, Howard L, Morgan C. Barriers to participation in mental
health research: findings from the Genetics and Psychosis (GAP)
Study. Int Rev Psychiatry 2011;23:31–40.
13. Shavers-Hornaday VL, Lynch CF, Burmeister LF, et al. Why are
African Americans under-represented in medical research studies?
Impediments to participation. Ethn Health 1997;2:31–45.
14. Callard F, Broadbent M, Denis M, et al. Developing a new model for
patient recruitment in mental health services: a cohort study using
Electronic Health Records. BMJ Open 2014;4:e005654.
15. Papoulias C, Robotham D, Drake G, et al. Staff and service users’
views on a ‘Consent for Contact’ research register within psychosis
services: a qualitative study. BMC Psychiatry 2014;14:377.
16. Robotham D, Evans J, Watson A, et al. Linking a research register
to clinical records in older adults’ mental health services:
a mixed-methods study. Alzheimers Res Ther 2015;7:15.
17. Furimsky I, Cheung AH, Dewa CS, et al. Strategies to enhance
patient recruitment and retention in research involving patients
with a first episode of mental illness. Contemp Clin Trials
2008;29:862–6.
18. Stewart R, Soremekun M, Perera G, et al. The South London and
Maudsley NHS Foundation Trust Biomedical Research Centre
(SLAM BRC) case register: development and descriptive data. BMC
Psychiatry 2009;9:51. http://www.biomedcentral.com/1471-244X/9/
51http://dx.doi.org/10.1186/1471-244X-9-51
19. Perera G, Broadbent M, Callard F, et al. Cohort profile of the South
London and Maudsley NHS Foundation Trust Biomedical Research
Centre (SLaM BRC) Case Register: current status and recent
enhancement of an Electronic Mental Health Record-derived data
resource. BMJ Open 2016;6:e008721.
20. Patel R, Shetty H, Jackson R, et al. Delays before diagnosis and
initiation of treatment in patients presenting to mental health services
with bipolar disorder. PLoS ONE 2015;10:e0126530.
21. Patel R, Jayatilleke N, Broadbent M, et al. Negative symptoms in
schizophrenia: a study in a large clinical sample of patients using a
novel automated method. BMJ Open 2015;5:e007619.
22. Patel R, Wilson R, Jackson R, et al. Association of cannabis use
with hospital admission and antipsychotic treatment failure in first
episode psychosis: an observational study. BMJ Open 2016;6:
e009888.
23. Patel R, Lloyd T, Jackson R, et al. Mood instability is a common
feature of mental health disorders and is associated with poor
clinical outcomes. BMJ Open 2015;5:e007504.
24. Patel R, Chesney E, Cullen AE, et al. Clinical outcomes and
mortality associated with weekend admission to psychiatric hospital.
Br J Psychiatry 2016;209:29–34. http://bjp.rcpsych.org/content/209/1/
29.abstracthttp://dx.doi.org/10.1192/bjp.bp.115.180307
25. Patel R, Reiss P, Shetty H, et al. Do antidepressants increase the
risk of mania and bipolar disorder in people with depression?
A retrospective electronic case register cohort study. BMJ Open
2015;5:e008341.
26. Fernandes AC, Cloete D, Broadbent MTM, et al. Development and
evaluation of a de-identification procedure for a case register
sourced from mental health electronic records. BMC Med Inform
Decis Mak 2013;13:71.
27. Mental Health Act. Great Britain: London: The Stationery Office,
2007. http://www.legislation.gov.uk/ukpga/2007/12/contents
28. Wing JK, Beevor AS, Curtis RH, et al. Health of the Nation Outcome
Scales (HoNOS). Research and development. Br J Psychiatry
1998;172:11–18.
29. Office for National Statistics. Ethnic Group. London. http://www.ons.
gov.uk/ons/guide-method/measuring-equality/equality/
ethnic-nat-identity-religion/ethnic-group/index.html
30. Cheah S, O’Donoghue S, Daudt H, et al. Permission to contact
(PTC)—a strategy to enhance patient engagement in translational
research. Biopreserv Biobank 2013;11:245–52.
31. Woodall A, Morgan C, Sloan C, et al. Barriers to participation in
mental health research: are there specific gender, ethnicity and age
related barriers? BMC Psychiatry 2010;10:103.
32. Baquet CR, Commiskey P, Daniel Mullins C, et al. Recruitment and
participation in clinical trials: socio-demographic, rural/urban, and
health care access predictors. Cancer Detect Prev 2006;30:24–33.
33. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical
trials: race-, sex-, and age-based disparities. JAMA
2004;291:2720–6.
34. Borschmann R, Patterson S, Poovendran D, et al. Influences on
recruitment to randomised controlled trials in mental health settings
in England: a national cross-sectional survey of researchers working
for the Mental Health Research Network. BMC Med Res Methodol
2014;14:23.
35. Sitzia J. Barriers to research utilisation: the clinical setting and
nurses themselves. Intensive Crit Care Nurs 2002;18:230–43.
36. LeBlanc J, Dee S, Braun L, et al. Impact of a Permission to Contact
(PTC) platform on biobank enrollment and efficiency. Biopreserv
Biobank 2013;11:144–8.
Patel R, et al. BMJ Open 2017;7:e013113. doi:10.1136/bmjopen-2016-013113 9
Open Access
